VCEL FY 2022 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$164M+5.2% YoY

Gross Profit

$110M66.8% margin

Operating Income

-$17M-10.4% margin

Net Income

-$17M-10.2% margin

EPS (Diluted)

$-0.35

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$10M

Stock-Based Comp.

$37M

Balance Sheet

Total Assets

$273M

Total Liabilities

$81M

Stockholders' Equity

$192M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$164M	$156M	+5.2%
Gross Profit	$110M	$106M	+3.5%
Operating Income	-$17M	-$8M	-117.2%
Net Income	-$17M	-$7M	-123.7%